Logo image of TRIB

TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Price, Quote, News and Overview

NASDAQ:TRIB - Nasdaq - US8964385046 - ADR - Currency: USD

1.32  -0.04 (-2.94%)

Premarket: 1.22 -0.1 (-7.58%)

TRIB Quote, Performance and Key Statistics

TRINITY BIOTECH PLC-SPON ADR

NASDAQ:TRIB (1/29/2025, 8:00:02 PM)

Premarket: 1.22 -0.1 (-7.58%)

1.32

-0.04 (-2.94%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.55
52 Week Low0.74
Market Cap36.33M
Shares27.52M
Float5.34M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO10-21 1992-10-21


TRIB short term performance overview.The bars show the price performance of TRIB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40 60

TRIB long term performance overview.The bars show the price performance of TRIB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TRIB is 1.32 USD. In the past month the price increased by 64.61%. In the past year, price decreased by -56%.

TRINITY BIOTECH PLC-SPON ADR / TRIB Daily stock chart

TRIB Latest News, Press Releases and Analysis

News Image
2 days ago - Chartmill

Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

News Image
2 days ago - Chartmill

Check out the stocks that are attracting the most attention and driving market activity.

Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.

News Image
2 days ago - Chartmill

These stocks are moving in today's session

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.

News Image
2 days ago - Chartmill

The market is filled with gapping stocks in Tuesday's session.

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.

News Image
6 minutes ago - FinancialNewsMedia

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END

TRIB Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.38 221.77B
ISRG INTUITIVE SURGICAL INC 78.13 203.99B
BSX BOSTON SCIENTIFIC CORP 43.52 151.38B
SYK STRYKER CORP 32.08 149.08B
MDT MEDTRONIC PLC 17.41 117.21B
BDX BECTON DICKINSON AND CO 18.76 71.60B
EW EDWARDS LIFESCIENCES CORP 26.64 41.95B
GEHC GE HEALTHCARE TECHNOLOGY 20.82 40.14B
RMD RESMED INC 30.5 37.12B
IDXX IDEXX LABORATORIES INC 38.24 34.29B
DXCM DEXCOM INC 50.84 33.76B
PHG KONINKLIJKE PHILIPS NVR- NY 20.36 25.64B

About TRIB

Company Profile

TRIB logo image Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. The company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The firm sells its products direct in the United States and through a network of international distributors.

Company Info

TRINITY BIOTECH PLC-SPON ADR

Ida Business Park, Bray, Co Wicklow

DUBLIN WICKLOW IE

CEO: Ronan O'Caoimh

Employees: 380

Company Website: https://www.trinitybiotech.com/

Investor Relations: http://www.trinitybiotech.com/investor-relations/

Phone: 1135312955111

TRIB FAQ

What is the stock price of TRIB?

The current stock price of TRIB is 1.32 USD.


What is the symbol for TRINITY BIOTECH PLC-SPON ADR stock?

The exchange symbol of TRINITY BIOTECH PLC-SPON ADR is TRIB and it is listed on the Nasdaq exchange.


On which exchange is TRIB stock listed?

TRIB stock is listed on the Nasdaq exchange.


Is TRIB a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TRIB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TRIB.


Does TRIB stock pay dividends?

TRIB does not pay a dividend.


What is the Price/Earnings (PE) ratio of TRIB?

TRIB does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.9).


What is the Short Interest ratio of TRIB stock?

The outstanding short interest for TRIB is 0.55% of its float.


TRIB Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to TRIB. When comparing the yearly performance of all stocks, TRIB is a bad performer in the overall market: 93.61% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

TRIB Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TRIB. Both the profitability and financial health of TRIB have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TRIB Financial Highlights

Over the last trailing twelve months TRIB reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS increased by 34.11% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -20.87%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%42.72%
Sales Q2Q%3.24%
EPS 1Y (TTM)34.11%
Revenue 1Y (TTM)-0.01%

TRIB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to TRIB. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -194.92% and a revenue growth 6.69% for TRIB


Ownership
Inst Owners8%
Ins OwnersN/A
Short Float %0.55%
Short Ratio0.16
Analysts
Analysts85.71
Price TargetN/A
EPS Next Y-194.92%
Revenue Next Year6.69%